1 Lunenfeld B, "Testosterone therapy in the aging male" 10 : 139-153, 2007
2 Gruenewald DA, "Testosterone supplementation therapy for older men: potential benefits and risks" 51 : 101-115, 2003
3 Becker HWG, "Testicular dysfunction in systemic disease, in : rinciples and practice of endocrinology and metabolism. 3th ed." Lippincott 2000
4 Rhoden EL, "Risks of testosterone-replacement therapy and recommendations for monitoring" 350 : 482-1492, 2004
5 Schubert M, "Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects" 28 : 23-27, 2005
6 Nieschlag E, "Investigation, treatment, and monitoring of Late-onset Hypogonadism in Males: ISA, ISSAM, and EAU recommendations" 27 : 135-137, 2006
7 Nieschlag E, "Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations" 28 : 125-127, 2005
8 Morales A, "International society for the study of the aging male: investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM" 5 : 74-86, 2002
9 Nieschlag E, "International Society of Andrology (ISA); International Society for the Study of the Aging Male (ISSAM); European Association of Urology (EAU). Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations" 48 : 1-4, 2005
10 Lunenfeld B, "ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale" 8 : 59-74, 2005
1 Lunenfeld B, "Testosterone therapy in the aging male" 10 : 139-153, 2007
2 Gruenewald DA, "Testosterone supplementation therapy for older men: potential benefits and risks" 51 : 101-115, 2003
3 Becker HWG, "Testicular dysfunction in systemic disease, in : rinciples and practice of endocrinology and metabolism. 3th ed." Lippincott 2000
4 Rhoden EL, "Risks of testosterone-replacement therapy and recommendations for monitoring" 350 : 482-1492, 2004
5 Schubert M, "Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects" 28 : 23-27, 2005
6 Nieschlag E, "Investigation, treatment, and monitoring of Late-onset Hypogonadism in Males: ISA, ISSAM, and EAU recommendations" 27 : 135-137, 2006
7 Nieschlag E, "Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations" 28 : 125-127, 2005
8 Morales A, "International society for the study of the aging male: investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM" 5 : 74-86, 2002
9 Nieschlag E, "International Society of Andrology (ISA); International Society for the Study of the Aging Male (ISSAM); European Association of Urology (EAU). Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations" 48 : 1-4, 2005
10 Lunenfeld B, "ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale" 8 : 59-74, 2005
11 Muller M, "Endogenous sex hormones and cardiovascular disease in men" 88 : 5076-5086, 2003
12 Mikio Namiki, "Clinical practice manual for late-onset hypogonadism syndrome" 15 : 377-388, 2008
13 Morley JE, "Andropause, testosterone therapy, and quality of life in aging men" 67 : 880-882, 2000